A Phase IIIB Double Blind, Randomized, Placebo-Controlled, Dose-Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects
Latest Information Update: 15 Jan 2020
At a glance
- Drugs Hyaluronidase (Primary)
- Indications Unspecified
- Focus Pharmacodynamics; Registrational
- Sponsors Halozyme Therapeutics
- 15 Jan 2020 New trial record